Skip to main content

Table 3 Aggregation of MedDRA PT codes by MedDRA SOCs

From: Standardizing adverse drug event reporting data

MedDRA SOC Code MedDRA SOC Terms PT Codes, No.1 AERS Reports, No. (%)2
10018065 General disorders and administration site conditions 595 875,070 (15.6)
10029205 Nervous system disorders 729 570,448 (10.2)
10017947 Gastrointestinal disorders 699 447,243 (8.0)
10022891 Investigations 2,748 407,270 (7.3)
10037175 Psychiatric disorders 453 329,198 (5.9)
10022117 Injury, poisoning, and procedural complications 697 311,952 (5.5)
10038738 Respiratory, thoracic, and mediastinal disorders 437 287,425 (5.1)
10028395 Musculoskeletal and connective tissue disorders 365 276,784 (4.9)
10040785 Skin and subcutaneous tissue disorders 390 273,674 (4.9)
10021881 Infections and infestations 1,361 267,741 (4.8)
Infections and infestations
10007541 Cardiac disorders 283 237,037 (4.2)
10047065 Vascular disorders 595 195,591 (3.5)
10027433 Metabolism and nutrition disorders 236 160,134 (2.9)
10038359 Renal and urinary disorders 288 132,055 (2.4)
10029104 Neoplasms benign, malignant and unspecified (incl. cysts and polyps) 1,293 129,227 (2.3)
10005329 Blood and lymphatic system disorders 218 122,276 (2.2)
10015919 Eye disorders 462 114,312 (2.0)
10042613 Surgical and medical procedures 1,176 89,005 (1.6)
10019805 Hepatobiliary disorders 162 79,067 (1.4)
10038604 Reproductive system and breast disorders 381 73,431 (1.3)
10021428 Immune system disorders 111 64,127 (1.1)
10041244 Social circumstances 189 48,077 (0.9)
10036585 Pregnancy, puerperium and perinatal conditions 182 36,959 (0.7)
10013993 Ear and labyrinth disorders 75 30,174 (0.5)
10010331 Congenital, familial, and genetic disorders 833 21,244 (0.4)
10014698 Endocrine disorders 129 18,053 (0.3)
  1. 1“PT Codes, No.” shows the number of PT codes for each SOC.
  2. 2“AERS Reports, No. (%)” shows the number of AERS reports and the percentage among the overall AERS report number for each SOC, where one report may contain several SOCs associated with several drugs.